FDA DEVICE FACTS
URiSCAN 10ACR urine strips on the URiSCAN Optima urine analyzer
Yd Diagnostics Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
for the in vitro qualitative and semi-quantitative measurement of the following parameters: blood, ketones (acetoacetic acid), protein, nitrite, glucose, pH, SG (specific gravity), leucocytes, albumin, creatinine, and ACR (albumin creatinine ratio). for the in vitro semi-quantitative measurement of the following parameters: Albumin, Creatinine, ACR (Albumin Creatinine Ratio)
for the in vitro qualitative and semi-quantitative measurement of urine parameters, specifically urobilinogen, glucose, ketones (acetoacetic acid), bilirubin, protein, nitrite, pH, blood, specific gravity, and leucocytes. Analytes measured blood, ketones (acetoacetic acid), protein, nitrite, glucose, pH, SG (specific gravity), leucocytes, albumin, creatinine. Albumin, Creatinine urobilinogen, glucose, ketones (acetoacetic acid), bilirubin, protein, nitrite, pH, blood, specific gravity, and leucocytes. Specimen Urine Same Same Result Type Qualitative and Semi-quantitative Semi-quantitative Qualitative and Semi-quantitative
IX Standards/Guidance Documents Referenced: Clinical and Laboratory Standards Institute (CLSI) EP05-A2, Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline - 2nd Ed
X Performance Characteristics (if/when applicable): The URiSCAN 10ACR urine strips’ test pads are a new combination of some of the test pads previously cleared in k050801 and k141874. There is no change to the chemistries or basic manufacturing processes of the pads.
A Analytical Performance:
1. Precision/Reproducibility: Within-run and within-day precision studies were performed at three point-of-care (POC) sites by three representative operators per site. The study included commercially available MAS Urinalysis Controls (Level 1 and Level 2) and 11 spiked urine pools to cover various -concentrations per analyte. Precision testing was done in accordance with the recommendations in the CLSI guideline EP5-A2.
Within-run precision: These studies used three different URiSCAN Optima urine analyzers and three different lots of URiSCAN 10ACR urine strips. Each of the three operators per site tested each control level and each urine pool in ten replicates within a run (N=90, 30 results per analyte x 3 sites).
Within-day precision: These studies used three different URiSCAN Optima urine analyzers and three different lots of URiSCAN 10ACR urine strips. Each of the three operators per site tested each control level and each urine pool once per day for 10 days at each site (N=90, 30 results per analyte x 3 sites).
Level 1 quality control Exact value Within-run (N=90) Within-day (N=90) Agreement within same grade Agreement within ± 1 grade Agreement within same grade Agreement within ± 1 grade Leucocytes ̶ 100% 100% 100% 100% Nitrite ̶ 100% 100% 100% 100% Blood ̶ 100% 100% 100% 100% pH 5.5 100% 100% 100% 100% Creatinine ± 100% 100% 100% 100% SG 1.015 100% 100% 100% 100% Ketones ̶ 100% 100% 100% 100% Microalbumin ̶ 100% 100% 100% 100% Protein ̶ 100% 100% 100% 100% Glucose ̶ 100% 100% 100% 100% ACR <30mg/g 100% 100% 100% 100%
Level 2 quality control Analyte Exact value Within-run (N=90) Within-day (N=90) Agreement within same grade Agreement within ± 1 grade Agreement within same grade Agreement within ± 1 grade Leucocytes 2+ 100% 100% 100% 100% Nitrite + 100% 100% 100% 100% Blood 3+ 100% 100% 100% 100% pH 7.0 100% 100% 100% 100% Creatinine 4+ 100% 100% 100% 100% SG 1.020 100% 100% 100% 100% Ketones 3+ 100% 100% 100% 100% - Level 2 quality control Analyte Exact value Within-run (N=90) Within-day (N=90) Agreement within same grade Agreement within ± 1 grade Agreement within same grade Agreement within ± 1 grade Microalbumin 3+ 100% 100% 100% 100% Protein 4+ 100% 100% 100% 100% Glucose 1+ 100% 100% 100% 100% ACR >300 mg/g 100% 100% 100% 100%
Sample Analyte Exact value Within-run (N=90) Within-day (N=90) Agreement within same
Agreement within ± 1 grade Agreement within same grade Agreement within ± 1 grade Pool 1 ALB ̶ 100% 100% 100% 100% CRE ± 100% 100% 100% 100% ACR <30 mg/g 100% 100% 100% 100% Pool 2 ALB + 100% 100% 100% 100% CRE + 100% 100% 100% 100% ACR 30-300 mg/g 100% 100% 100% 100% Pool 3 ALB 2+ 100% 100% 100% 100% CRE 2+ 100% 100% 100% 100% ACR 30-300 mg/g 100% 100% 100% 100% Pool 4 ALB 3+ 100% 100% 100% 100% CRE 3+ 100% 100% 100% 100% ACR 30-300 mg/g 100% 100% 100% 100% Pool 5 ALB ̶ 100% 100% 100% 100% CRE 4+ 100% 100% 100% 100% ACR <30 mg/g 100% 100% 100% 100% Pool 6 Leucocyte
̶ 100% 100% 100% 100% Nitrite ̶ 100% 100% 100% 100% Blood ̶ 100% 100% 100% 100% pH 5 100% 100% 100% 100% SG 1.000 100% 100% 100% 100% Ketones ̶ 100% 100% 100% 100% Protein ̶ 100% 100% 100% 100% Glucose ̶ 100% 100% 100% 100% Leucocyte
± 100% 100% 100% 100% Pool 7 Nitrite + 100% 100% 100% 100% Blood ± 100% 100% 100% 100% pH 6 100% 100% 100% 100% SG 1.005 100% 100% 100% 100% Ketones ± 100% 100% 100% 100% Protein ± 100% 100% 100% 100% - Sample Analyte Exact value Within-run (N=90) Within-day (N=90) Agreement within same d Agreement within ± 1 grade Agreement within same grade Agreement within ± 1 grade Glucose ± 96.7% 100% 100% 100% Pool 8 Leucocyte
+ 100% 100% 100% 100% Nitrite ̶ 100% 100% 100% 100% Blood + 100% 100% 100% 100% pH 7 100% 100% 100% 100% SG 1.010 100% 100% 100% 100% Ketones + 100% 100% 100% 100% Protein + 100% 100% 100% 100% Glucose + 93.3% 100% 96.7% 100% Pool 9 Leucocyte
2+ 100% 100% 100% 100% Nitrite ̶ 100% 100% 100% 100% Blood 2+ 100% 100% 100% 100% pH 8 100% 100% 100% 100% SG 1.020 100% 100% 100% 100% Ketones 2+ 100% 100% 100% 100% Protein 2+ 100% 100% 100% 100% Glucose 2+ 96.7% 100% 93.3% 100% Pool 10 Leucocyte
3+ 100% 100% 100% 100% Nitrite ̶ 100% 100% 100% 100% Blood 3+ 100% 100% 100% 100% pH 9 100% 100% 100% 100% SG 1.025 100% 100% 100% 100% Ketones 3+ 100% 100% 100% 100% Protein 3+ 100% 100% 100% 100% Glucose 3+ 93.3% 100% 93.3% 100% Pool 11 Leucocytes ̶ 100% 100% 100% 100% Nitrite ̶ 100% 100% 100% 100% Blood ̶ 100% 100% 100% 100% SG 1.030 100% 100% 100% 100% Ketones ̶ 100% 100% 100% 100% Protein 4+ 100% 100% 100% 100% Glucose 4+ 100% 100% 100% 100%
2. Linearity: The test pads are unchanged. The claims remain the same as those established in k050801 and k141874.
3. Analytical Specificity/Interference: The test pads are unchanged. The claims remain the same as those established in k050801 and k141874. -
4. Assay Reportable Range: The test pads are unchanged. The claims remain the same as those established in k050801 and k141874.
5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods): The test pads are unchanged. The claims remain the same as those established in k050801 and k141874.
6. Detection Limit: The test pads are unchanged. The claims remain the same as those established in k050801 and k141874.
7. Assay Cut-Off: Not applicable.
8. Carry over study: Studies were performed to evaluate the effect of run-over from adjacent pads using 43 urine samples covering up to six concentrations for each analyte. The strips were dipped into a urine sample, and then upon removal, held vertically in either upwards or downward directions for 5, 10, 15, and 20 seconds to allow the sample to run over adjacent pads. Testing was performed with three lots of strips on three analyzers, in replicates of three.
The results support the claim that if the test strip is handled appropriately according to the package insert (dip into the urine for 1 second, blot strip immediately after removing strip from urine cup and place on the instrument’s strip holder without delay), the results are not impacted. If excessive urine remains on the strip because of improper test procedure, then pH result may be higher than the actual value due to run over effect. The sponsor includes this information in the labeling.
B Comparison Studies:
1. Method Comparison with Predicate Device: Method comparison studies were performed by nine representative POC operators (three operators per site) at three POC sites. A total of 407 natural patient samples were tested across the three sites: 135 samples at Site 1, 143 samples at Site 2, and 129 samples at Site 3. The operators tested fresh urine specimens with the URiSCAN 10ACR urine strips (candidate device) and the URiSCAN 2ACR urine strips (k141874) and URiSCAN urine strips (k050801), all on the URiSCAN Optima urine analyzer, in a blinded fashion. The comparisons between the candidate and predicate results are shown below:
Albumin (N=407) Predicate device (mg/L) 10 30 80 150 URiSCAN 10 ACR strip (mg/L) 3+ 6 79 2+ 4 105 2 1+ 108 1 Neg. 102 Total 102 112 112 81 Exact agreement (%) 100 96 94 98 Within One Block (%) 100 100 100 100 -
Creatinine (N=407) Predicate device (mg/dL) 10 50 100 200 300 URiSCAN 10 ACR strip (mg/dL) 4+ 3 42 3+ 2 75 2 2+ 1 98 1 1+ 3 109 3 + - 68 Total 71 110 103 79 44 Exact agreement (%) 96 99 95 95 95 Within One Block (%) 100 100 100 100 100
ACR (N=407) Predicate device (mg/g) <30 30-300 >300 URiSCAN 10 ACR strip (mg/g) >300 2 61 30-300 2 199 2 <30 137 4 Total 139 205 63 Exact agreement (%) 99 97 97 Within One Block (%) 100 100 100
Blood (N=407) Predicate device (RBC/uL) Neg. +- 1+ 2+ 3+ URiSCAN 10 ACR strip (RBC/uL) 3+ 1 43 2+ 34 1 1+ 2 40 1 +- 4 46 2 Neg. 232 1 Total 236 49 42 36 44 Exact agreement (%) 98 94 95 94 98 Within One Block (%) 100 100 100 100 100
Ketones (N=407) Predicate device (mg/dL) Neg. +- 1+ 2+ 3+ URiSCAN 10 ACR strip (mg/dL) 3+ 1 16 2+ 29 1+ 1 23 2 +- 4 32 Neg. 297 2 Total 301 35 23 32 16 Exact agreement (%) 99 91 100 91 100 Within One Block (%) 100 100 100 100 100 - Protein (N=407) Predicate device (mg/dL) Neg +- 1+ 2+ 3+ 4+ URiSCAN 10 ACR strip (mg/dL) 4+ 10 3+ 2 25 2+ 1 44 1 1+ 46 1 +- 2 45 2 Neg. 225 3 Total 227 48 49 47 26 10 Exact agreement (%) 99 94 94 94 96 100 Within One Block (%) 100 100 100 100 100 100
Nitrite (N=407)
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。